The significant increase of inflammatory biomarkers, such as serum amyloid A, IL-6, and CRP in severe COVID-19 patients (53), are directly or indirectly linked to adipocytes with sub-clinical low-grade inflammation that further exacerbates COVID-19 severity in individuals with obesity (54, 55). Here, IL6 is linked to obesity due to melanocortin 4 receptor deficiency.